Estimated read time: 3-4 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] HEA HIN MEQ MTC IDC
[SU] PDT
-- WITH PHOTO -- TO BUSINESS EDITORS:
Daylight Medical Launches SKY 6Xi Disinfection Technology For
Healthcare
CLEVELAND, April 15, 2014 /PRNewswire/ -- Daylight Medical,
manufacturer and provider of innovative medical products, is pleased
to announce its rollout of SKY 6Xi, disinfection technology for mobile
devices. SKY 6Xi uses high intensity (254 nanometer wavelength)
ultraviolet light in the "C" spectrum (UVC) at close proximity to
thoroughly disinfect a mobile device. The unique power of SKY reduces
the risk that Hospital-acquired infections (HAIs) are transmitted to
patients while improving safety for healthcare workers.
The prevalence of HAIs remains a serious problem for caregivers. The
Centers for Disease Control (CDC) reports that one in 25 patients in
U.S. hospitals acquires a HAI as part of his or her care, and reflects
only modest progress in controlling pathogens in medical facilities.
With the increased prevalence of mobile devices in healthcare, there
is a need for hospitals to address the pathogens that can live or be
transported on them. Whether hospitals provide mobile devices or
staffs bring their own device (BYOD), they are vectors of
contamination requiring careful disinfection to be used safely in the
healthcare setting. SKY 6Xi provides safe, effective disinfection of
phones and tablet PCs in seconds, protecting patients and healthcare
staff from harmful pathogens that can be transmitted from these
high-touch surfaces.
"SKY was designed with the busy healthcare provider in mind. It's easy
to use and can thoroughly disinfect a mobile device within 30 seconds,
phones within 10 seconds. SKY can be used in any area of the hospital
and takes the guesswork out of whether or not a device is
contaminated," says Rick Dayton, President of Daylight Medical. "This
is important when you consider the risk of transmission from mobile
devices, not only to patients, but also to hospital staff."
SKY was designed to address harmful pathogens such as MRSA, VRE,
MDR-gram negatives, Norovirus and C. diff spores using high intensity
UVC to penetrate the cells of pathogens, viruses, bacteria and spores.
SKY breaks the DNA strand of the pathogen at the point responsible for
cell replication, rendering the organism inactive and achieving a 3 to
6 log reduction (99.9% to 99.9999.
SKY's market release is timely. Last month, the CDC reported that atop
the list of pathogens acquired in hospitals is the bacterium
clostridium difficile (commonly know as C. diff), which can cause
gastroenterological illnesses so severe that removal of a patient's
colon is sometimes required. It was responsible for 12.1 percent of
the infections turned up by the survey. SKY 6Xi has been proven to
reduce C. diff by just under 4 log.
Unique to SKY, Daylight Medical offers sleeve technology enabling
mobile devices to be taken into critical care environments while
protecting the device and eliminating pathogen accumulation in the
recess (charging jack, earphone inputs). SKY sleeves, which are
specially manufactured allowing maximum UV light transmittance, can be
purchased with photochromic markers. When a mobile device is placed in
a SKY photochromic sleeve, a checkmark is revealed when it is exposed
to high intensity UVC light during the disinfection process. The
marker is a visual notification the device has been successfully
processed. Device disinfection can be done as often as required by
hospital protocol and in accord with Infection Control mandates.
*All results based on independent testing. C. difficile was tested
directly and, for safety and equivalence, challenge organisms of
greater irradiation resistance replaced other pathogens noted. Tests
conducted with Pseudomonas aeruginosa, Staphylococcus aureus, and
Bacillus atrophaeus.
Read more news from Daylight Medical.
Contact: Gayle Harper 800-459-8500 x 226 Email
Photo - http://photos.prnewswire.com/prnh/20140414/73061
Photo - http://photos.prnewswire.com/prnh/20140414/73060
SOURCE Daylight Medical
-0- 04/15/2014
/Photo: http://photos.prnewswire.com/prnh/20140414/73061
http://photos.prnewswire.com/prnh/20140414/73060
PRN Photo Desk, photodesk@prnewswire.com
CO: Daylight Medical
ST: Ohio
IN: HEA HIN MEQ MTC IDC
SU: PDT
PRN
-- PH04856 --
0000 04/15/2014 12:30:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
